A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity?

European Neuropsychopharmacology

Volumn 12, Issue 4, 2002, Pages 349-354

  Condren, Rita M ^a   Dinan, Timothy G ^b   Thakore, Jogin H ^a  

^a St Vincent's Hospital Ireland   (Ireland)

^b University College Cork and INFANT Centre   (Ireland)

Author keywords

Buspirone; Dopamine; Prolactin; Serotonin; Social phobia

Indexed keywords

BUSPIRONE; PARTIAL AGONIST; PROLACTIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN AGONIST;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRELIMINARY COMMUNICATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; SEROTONINERGIC SYSTEM; SOCIAL PHOBIA; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; MIDDLE AGED; PHOBIA; SECRETION;

ADULT; AREA UNDER CURVE; BUSPIRONE; FEMALE; HUMAN; MALE; MIDDLE AGE; PHOBIC DISORDERS; PROLACTIN; SEROTONIN AGONISTS; HUMANS; MIDDLE AGED;

EID: 0036019881     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(02)00043-3     Document Type: Article

References (59)

1. Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers
2. Prolactin response to DL-fenfluramine in panic disorder
3. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome
4. The neurobiology of social phobia
5. Neuroendocrine regulation of prolactin release
6. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses
7. Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment
8. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects
9. Serotonin function and human anxiety disorders
10. An investigation into the psychobiology of social phobia: personality domains and serotonergic function
11. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome
12. Preliminary evidence of a serotonin (5-HT-1-like) component to the prolactin response to buspirone challenge in humans
13. The role of cortisol in spontaneous and stimulated prolactin release
14. The reproducibility of the prolactin response to buspirone: relationship to the menstrual cycle
15. A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia-are central serotonergic responses enhanced?
16. Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study
17. Behavioural and endocrine responses to clomipramine in panic disorder patients with or without alcoholism
18. Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage
19. Role of 5-HT in stress, anxiety and depression
20. Metergoline abolishes the prolactin response to buspirone
21. Effects of local application of 5-HT and 8-OHDPAT into the dorsal and median raphe nuclei on core temperature of the rat
22. Serotonergic function in social phobia: comparison to normal controls and obsessive-compulsive disorder subjects
23. 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues
24. Plasma and CSF HVA levels in panic patients with comorbid social phobia
25. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine
26. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder
27. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects
28. Regulation of prolactin secretion at the level of the lactotroph
29. Social phobia
30. Possible dopamine dysregulation in social phobia and atypical depression
31. Salivary cortisol levels in socially phobic adolescent girls
32. The effect of buspirone on prolactin and growth hormone secretion in man
33. Neuroendocrine effects of buspirone: mediation by dopaminergic and serotonergic mechanisms
34. Effect of buspirone on prolactin secretion is not mediated by 5HT1A receptor stimulation
35. School avoidance and social phobia triggered by haloperidol in patients with Tourette's syndrome
36. Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat
37. Neuroendocrine effects of buspirone
38. Levels of urinary free cortisol in social phobia
39. Low dopamine D2 receptor binding potential in social phobia
40. Serum prolactin levels after buspirone in man
41. Increased prolactin response to buspirone in chronic fatigue syndrome
42. Neurobiological perspectives on social phobia: from affiliation to zoology
43. Anxiety disorders in patients with Parkinson's disease
44. 3H]Paroxetine binding to platelets of patients with panic disorder and healthy volunteers
45. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia
46. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression
47. Dopamine reuptake site densities in patients with social phobia
48. Molecular basis of buspirone's anxiolytic action
49. Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers
50. The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials
51. Hormonal probes of central serotonergic activity: do they really exist?
52. Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome
53. Serotonin receptors, buspirone, and premenstrual syndrome
54. Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome